EP3380099A4 - Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci - Google Patents

Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci Download PDF

Info

Publication number
EP3380099A4
EP3380099A4 EP16869062.6A EP16869062A EP3380099A4 EP 3380099 A4 EP3380099 A4 EP 3380099A4 EP 16869062 A EP16869062 A EP 16869062A EP 3380099 A4 EP3380099 A4 EP 3380099A4
Authority
EP
European Patent Office
Prior art keywords
urination
composition
making
reducing frequency
frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16869062.6A
Other languages
German (de)
English (en)
Other versions
EP3380099A1 (fr
Inventor
David A. Dill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellesley Pharmaceuticals LLC
Original Assignee
Wellesley Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/949,220 external-priority patent/US20160074397A1/en
Application filed by Wellesley Pharmaceuticals LLC filed Critical Wellesley Pharmaceuticals LLC
Publication of EP3380099A1 publication Critical patent/EP3380099A1/fr
Publication of EP3380099A4 publication Critical patent/EP3380099A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16869062.6A 2015-11-23 2016-11-10 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci Withdrawn EP3380099A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/949,220 US20160074397A1 (en) 2013-03-13 2015-11-23 Composition for reducing frequency of urination, method of making and use thereof
PCT/US2016/061350 WO2017091362A1 (fr) 2015-11-23 2016-11-10 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci

Publications (2)

Publication Number Publication Date
EP3380099A1 EP3380099A1 (fr) 2018-10-03
EP3380099A4 true EP3380099A4 (fr) 2019-11-27

Family

ID=58764243

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16869062.6A Withdrawn EP3380099A4 (fr) 2015-11-23 2016-11-10 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci

Country Status (9)

Country Link
EP (1) EP3380099A4 (fr)
JP (1) JP2018538279A (fr)
KR (1) KR20180094512A (fr)
CN (1) CN108289891A (fr)
AU (1) AU2016359141A1 (fr)
HK (1) HK1257452A1 (fr)
SG (1) SG11201805362XA (fr)
TW (1) TW201726114A (fr)
WO (1) WO2017091362A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013103390A1 (fr) * 2012-01-04 2013-07-11 Wellesley Pharmaceuticals, Llc Formulation à libération prolongée pour réduire la fréquence de miction et son procédé d'utilisation
US20130287821A1 (en) * 2010-07-08 2013-10-31 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20130323288A1 (en) * 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
GB201003734D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
US10105330B2 (en) * 2012-01-04 2018-10-23 Wellesley Pharmaceuticals, Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
RU2015106762A (ru) * 2012-07-27 2016-09-20 УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Фармацевтическая композиция для лечения недержания мочи и способ ее применения
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130287821A1 (en) * 2010-07-08 2013-10-31 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20130323288A1 (en) * 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
WO2013103390A1 (fr) * 2012-01-04 2013-07-11 Wellesley Pharmaceuticals, Llc Formulation à libération prolongée pour réduire la fréquence de miction et son procédé d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2017091362A1 *

Also Published As

Publication number Publication date
HK1257452A1 (zh) 2019-10-18
CN108289891A (zh) 2018-07-17
WO2017091362A1 (fr) 2017-06-01
KR20180094512A (ko) 2018-08-23
JP2018538279A (ja) 2018-12-27
SG11201805362XA (en) 2018-07-30
EP3380099A1 (fr) 2018-10-03
AU2016359141A1 (en) 2018-07-05
TW201726114A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
EP3361987A4 (fr) Greffons de tissu mou, et leurs procédés de fabrication et d'utilisation
EP3356308A4 (fr) Particules poreuses à base de silicate et de calcium, composition, procédé de fabrication et d'utilisation associé
AU2015287923B2 (en) Hollow metalscrew and method of making
EP3352577A4 (fr) Compositions à base de cannabinoïdes et leurs procédés de production
EP3212184A4 (fr) Tétrahydropyrannes substitués et méthode d'utilisation associée
EP3234060A4 (fr) Composition de fracturation hydraulique, son procédé de production et d'utilisation
EP3261598A4 (fr) Noyau absorbant jetable et ensemble absorbant jetable le comprenant, et son procédé de fabrication
EP3269711A4 (fr) Forme cristalline ii, stable, d'aprémilast, exempte de solvates et son procédé de préparation
EP3328253A4 (fr) Appareil formant toilettes et son procédé d'utilisation
EP3373910A4 (fr) Formulation d'échinomycine, procédé de fabrication et méthode d'utilisation de cette dernière
EP3129094A4 (fr) Bougie et son procédé de fabrication et d'utilisation
EP3476872A4 (fr) Matériau d'électrolyte, son procédé de production et son utilisation
EP3535434A4 (fr) Composés de cobalt, procédé de fabrication et procédé d'utilisation associé
EP3297573A4 (fr) Endoprothèse et procédé d'utilisation
EP3313993A4 (fr) Anticorps anti-apobec3 et leurs procédés de fabrication et d'utilisation
EP3678485A4 (fr) Composition de chargement de liquide, et son procédé de fabrication et d'utilisation
EP3284747A4 (fr) Substance amorphe d'idélalisibe et procédé de préparation associé
EP3039107A4 (fr) Composition d'aide au rinçage solide et son procédé de fabrication
EP3179971A4 (fr) Noyau absorbant exempt de pâte à papier et procédé de formation de noyau
EP3530650A4 (fr) Forme cristalline de (r)-4-hydroxy-2-oxo-1-pyrrolidineacétamide, son procédé de préparation et son utilisation
EP3367998A4 (fr) Nouveau procédé d'utilisation et compositions
EP3530260A4 (fr) Procédé de prévention de l'oxydation d'un matériau antioxydant à l'aide d'un aptamère, matériau et utilisation de celui-ci
EP3326384A4 (fr) Haut-parleur et son procédé de fabrication
EP3309547A4 (fr) Composition de séparation de sérum ou de plasma, récipient de test sanguin, et procédé de stabilisation de la composition de séparation de sérum ou de plasma
EP3081581A4 (fr) Diazorésine, composition de résine photosensible et procédé de préparation de la composition de résine photosensible

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20180615

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/50 20060101AFI20190710BHEP

Ipc: A61K 31/4985 20060101ALI20190710BHEP

Ipc: A61K 31/167 20060101ALI20190710BHEP

Ipc: A61K 9/16 20060101ALI20190710BHEP

Ipc: A61K 31/405 20060101ALI20190710BHEP

Ipc: A61K 31/12 20060101ALI20190710BHEP

Ipc: A61K 31/616 20060101ALI20190710BHEP

Ipc: A61K 31/437 20060101ALI20190710BHEP

Ipc: A61K 31/192 20060101ALI20190710BHEP

Ipc: A61K 9/20 20060101ALI20190710BHEP

Ipc: A61K 45/06 20060101ALI20190710BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20191029

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/616 20060101ALI20191023BHEP

Ipc: A61K 31/4985 20060101ALI20191023BHEP

Ipc: A61K 31/167 20060101ALI20191023BHEP

Ipc: A61K 31/405 20060101ALI20191023BHEP

Ipc: A61K 31/437 20060101ALI20191023BHEP

Ipc: A61K 31/12 20060101ALI20191023BHEP

Ipc: A61K 9/16 20060101ALI20191023BHEP

Ipc: A61K 9/50 20060101AFI20191023BHEP

Ipc: A61K 31/192 20060101ALI20191023BHEP

Ipc: A61K 45/06 20060101ALI20191023BHEP

Ipc: A61K 9/20 20060101ALI20191023BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200603